Hemo Organic Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	0.11	0.09	1.29	1.17	0.09
Cash & Short-Term Investments	0.11	0.09	1.29	1.17	0.09
Cash Growth	25.29%	-93.23%	10.29%	1163.13%	-32.42%
Accounts Receivable	23.89	25.18	0.83	0.59	0.59
Other Receivables	6.89	7.52	7.1	0.07	-
Receivables	39.39	32.69	7.93	0.66	0.59
Inventory	5.08	14.16	-	0.15	0.17
Other Current Assets	-	-	-	0.04	0.11
Total Current Assets	44.58	46.94	9.22	2.02	0.97
Property, Plant & Equipment	0.03	0.02	0.02	0.02	0.02
Long-Term Deferred Tax Assets	-	2.79	1.41	1.41	1.41
Total Assets	44.61	49.76	10.64	3.44	2.39
Accounts Payable	15.61	36.33	1.06	1.07	1.11
Accrued Expenses	0.06	0.09	0.05	-	-
Other Current Liabilities	0.2	0.06	0.31	2.53	0.89
Total Current Liabilities	15.87	36.47	1.42	3.6	2.01
Long-Term Debt	27.41	14.8	12.38	0.35	0.35
Long-Term Deferred Tax Liabilities	0.01	0.01	-	-	-
Total Liabilities	43.28	51.27	13.8	3.96	2.36
Common Stock	34.66	34.66	34.66	34.66	34.66
Retained Earnings	-43.96	-36.17	-37.81	-35.17	-34.62
Comprehensive Income & Other	10.63	-	-	-	-
Shareholders' Equity	1.33	-1.52	-3.15	-0.51	0.03
Total Liabilities & Equity	44.61	49.76	10.64	3.44	2.39
Total Debt	27.41	14.8	12.38	0.35	0.35
Net Cash (Debt)	-27.3	-14.71	-11.09	0.81	-0.26
Net Cash Per Share	-7.86	-4.24	-3.20	0.23	-0.07
Filing Date Shares Outstanding	3.46	3.47	3.47	3.47	3.47
Total Common Shares Outstanding	3.46	3.47	3.47	3.47	3.47
Working Capital	28.71	10.47	7.8	-1.59	-1.04
Book Value Per Share	0.38	-0.44	-0.91	-0.15	0.01
Tangible Book Value	1.33	-1.52	-3.15	-0.51	0.03
Tangible Book Value Per Share	0.38	-0.44	-0.91	-0.15	0.01
Machinery	-	0.03	0.03	0.03	0.03